REG - SThree plc - Purchase of shares into the EBT

SThreeAnnouncement

Today 12:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260102:nRSB4945Na&default-theme=true

RNS Number : 4945N  SThree plc  02 January 2026

 2 January 2026

SThree plc

 

Purchase of shares into the EBT

 

SThree plc (the "Company"), the global STEM workforce consultancy, announces
that it has been notified that between 17 December 2025 and 30 December 2025
Computershare Trustees (Jersey) Limited, as Trustee of SThree Employees' Share
Ownership Plan Trust (the EBT), has purchased 400,478 ordinary shares of
£0.01 each in the Company as follows:

 

 Date        Exchange  Number of ordinary shares  Purchase price  Average purchase price per share
 17/12/2025  XLON      51,808                     £94,921         £1.832174
 18/12/2025  XLON      57,285                     £105,642        £1.844161
 19/12/2025  XLON      76,660                     £141,440        £1.845033
 22/12/2025  XLON      21,931                     £40,418         £1.842966
 23/12/2025  XLON      80,223                     £149,154        £1.859248
 24/12/2025  XLON      14,000                     £26,110         £1.865044
 29/12/2005  XLON      57,346                     £108,931        £1.899545
 30/12/2025  XLON      41,225                     £78,155         £1.895832
 Total                                                    £744,771

 

The shares will be held in the EBT, which is a discretionary trust for the
benefit of the Group's employees, and used to satisfy awards under certain
employee share schemes.

Further to this purchase, the EBT holds a total of 977,032 ordinary shares
which represents 0.76% of the Company's issued share capital.

 

Bill Warner

Deputy Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUUOARNBUARAR



            Copyright 2019 Regulatory News Service, all rights reserved